{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:08:41Z","timestamp":1789715321228,"version":"4.0.1"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>Differentiating metastatic breast carcinoma in the lungs from primary lung tumors and mesotheliomas is important for determining prognosis and treatment. We evaluated novel breast specific markers, androgen receptor (<jats:styled-content style=\"fixed-case\">AR<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">GATA<\/jats:styled-content> binding protein 3 (<jats:styled-content style=\"fixed-case\">GATA3<\/jats:styled-content>) immunohistostaining, for this differential, and compare to other traditional markers. The specimens comprised 33 metastatic breast carcinomas to the lung, 566 primary lung tumors (170 adenocarcinomas, 157 squamous cell carcinomas, 31 pleomorphic carcinomas, 115 large cell neuroendocrine carcinomas, 43 small cell carcinomas, and 49 typical carcinoids) and 42 malignant mesotheliomas. They were analyzed by immunohistochemistry using antibodies to <jats:styled-content style=\"fixed-case\">AR<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">GATA3<\/jats:styled-content>, estrogen receptor (<jats:styled-content style=\"fixed-case\">ER<\/jats:styled-content>), progesterone receptor (<jats:styled-content style=\"fixed-case\">PgR<\/jats:styled-content>), mammaglobin, gross cystic disease fluid protein\u201015 (<jats:styled-content style=\"fixed-case\">GCDFP<\/jats:styled-content>\u201015). Of the metastatic breast carcinomas, immunohistostaining of <jats:styled-content style=\"fixed-case\">AR<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">GATA3<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">ER<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">PgR<\/jats:styled-content>, mammaglobin, <jats:styled-content style=\"fixed-case\">GCDFP<\/jats:styled-content>\u201015 were positive in 27 cases (81.8%), 24 cases (72.7%), 26 cases (78.8%), 13 cases (39.4%), 12 cases (36.4%), 9 cases (27.3%), respectively. Of primary lung tumors and mesotheliomas, staining of <jats:styled-content style=\"fixed-case\">AR<\/jats:styled-content>, GATA3, <jats:styled-content style=\"fixed-case\">ER<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">PgR<\/jats:styled-content>, mammaglobin, <jats:styled-content style=\"fixed-case\">GCDFP<\/jats:styled-content>\u201015 were positive in 18 cases (3%), 3 cases (0.5%), 4 cases (0.7%), 2 cases (0.3%), 0 case (0%), 2 cases (0.3%), respectively. Immunohistochemistry of <jats:styled-content style=\"fixed-case\">AR<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">GATA3<\/jats:styled-content> are reliable for differentiating metastatic breast carcinoma from primary lung tumors and mesotheliomas.<\/jats:p>","DOI":"10.1111\/pin.12278","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T08:32:18Z","timestamp":1425285138000},"page":"286-292","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of androgen receptor and <scp>GATA<\/scp> binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung"],"prefix":"10.1111","volume":"65","author":[{"given":"Yukinori","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Pathology and Clinical Laboratories National Cancer Center Hospital  Tokyo Japan"},{"name":"Department of Pathology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Laboratories National Cancer Center Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Laboratories National Cancer Center Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pathology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuta","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Laboratories National Cancer Center Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)91639-X"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1309\/TDP92PQLDE2HLEET"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5858\/2008-132-239-AOEPOB","article-title":"Analysis of expression patterns of breast cancer\u2010specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors","volume":"132","author":"Takeda Y","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_5_1","volume-title":"WHO Classification of Tumours of the Breast","author":"Lakhani SR","year":"2012"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e31819faa07"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.38"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.54"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.159"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183656"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-149"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11532"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0770-6"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201586"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26061"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746\u20101596\u20101\u201034"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800437"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1309\/RVTP1G0Q727WJUQD"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-010-0494-3"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911404223"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.11.003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182a28a68"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318260cde7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.76"},{"key":"e_1_2_6_26_1","volume-title":"Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart","author":"Travis WD","year":"2004"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.08.007"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.12.022"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182a0218f"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.14.3.2201"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25506"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpin.12278","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pin.12278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:51:46Z","timestamp":1695549106000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pin.12278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/pin.12278"],"URL":"https:\/\/doi.org\/10.1111\/pin.12278","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,2]]}}}